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Abstract: A new label-free electrochemical DNA (E-DNA) biosensor using a custom 13 
synthesized ferrocenyl (Fc) double-stranded DNA (dsDNA) intercalator as a redox marker is 14 
presented. Single-stranded DNA (ssDNA) was co-immobilized on gold electrodes with 6-15 
mecarpto-hexanol (MCH) to control the surface density of the ssDNA probe, and hybridized 16 
with complementary DNA. The binding of the Fc intercalator to dsDNA was measured by 17 
differential pulse voltammetry (DPV). This new biosensor was optimized to allow the 18 
detection of single base pair mismatched sequences and, able to detect as low as 10 pM target 19 
ssDNA with a dynamic range from 10 pM to 100 nM. DNA extracted from wastewater was 20 
analysed by quantitative polymerase chain reaction (qPCR) targeting human-specific 21 
mitochondrial DNA (mtDNA). The aim of this approach is to enable the analysis of 22 
population biomarkers in wastewater for the evaluation of public health using wastewater-23 
based epidemiology (WBE). The E-DNA biosensor was employed to detect human-specific 24 
mtDNA from wastewater before and after PCR amplification. The results demonstrate the 25 
feasibility of detecting DNA biomarkers in wastewater using the developed biosensor, which 26 
may allow the further development of DNA population biomarkers for public health using 27 
WBE.   28 
Keywords: population biomarkers, wastewater-based epidemiology, DNA biosensor, 29 
intercalator,  30 
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1. Introduction 31 
            Wastewater-based epidemiology (WBE) has shown to be a powerful tool for the 32 
evaluation of community-wide drug1-3, alcohol4 and tobacco use5, and has the potential to be 33 
utilized for the evaluation of public health by assessing disease biomarkers6. The approach is 34 
based on the analysis of specific urinary biomarkers such as drug residues and/or their 35 
metabolites in wastewater following their excretion by humans, using urban wastewater 36 
collected at a treatment plant selected for sampling. WBE is a cost-effective, fast and near 37 
real-time tool for the evaluation of population health compared with traditional questionnaire 38 
survey approaches7. Until now, the quantitative measurement of specific drug biomarkers in 39 
wastewater has been performed to study the drug use habits of numerous communities1, 3. As 40 
an example, illicit drug use trends were recently evaluated in 21 countries (42 cities, total 41 
population 24.74 million) across Europe3. Furthermore, some drugs and their metabolites 42 
have also been proposed as a potential population biomarker for WBE such as creatinine8, 43 
cholesterol and coprostanol9, as well as caffeine and nicotine metabolites10. Chen et al 11 44 
outlined criteria for a candidate population biomarker: (1) must be quantifiable; (2) have little 45 
affinity to particulate matter in wastewater or to filter paper; (3) be stable in wastewater; (4) 46 
be constantly excreted and (5) the total excretion should correlate with census population, 47 
meaning there should be no contribution other than human metabolism. The potential 48 
population biomarkers reported in the literature were evaluated by Chen et al11 and few of 49 
them could strictly meet the proposed criteria. The major limitation of these chemical 50 
biomarkers is that they rely on the stability and the contribution from non-human metabolism.   51 
             Completion of sequencing the human genome in 2003 has shown that up to 1% of the 52 
human coding sequences are associated to cancer by mutation12. This valuable information is 53 
increasingly being utilized for diagnostic purposes by using known cancer associated 54 
mutations as biomarkers13-16. DNA is a surprisingly resilient biomolecule capable of 55 
persisting in the environment for many centuries, as shown by the complete genome 56 
sequencing of a Neanderthal individual from a bone sample17. DNA is also naturally shed 57 
into the environment by virtually all living organisms through urine, faeces, exudates or 58 
tissue residues as demonstrated by the advent of environmental DNA studies18. These robust 59 
characteristics have allowed the association of human specific mitochondrial DNA (mtDNA) 60 
to human faecal contamination to assess water quality19, 20. Since mtDNA also has mutations 61 
known to be associated to cancer21, 22, with a high copy number per cell23, it has the potential 62 
to be suitable for evaluating the feasibility of using novel analytical tools like biosensors to 63 
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detect human specific DNA from wastewater samples, with the perspective of further 64 
developing the system to identify population biomarkers for WBE studies. Consequently, 65 
mtDNA is clearly a potential population biomarker for WBE because it meets the outlined 66 
criteria such as stability, being associated to cancer, presenting human specific sequences and 67 
being quantifiable. 68 
            Electrochemical biosensors have great promise for the detection of disease biomarkers 69 
in body fluids, in particular due to being cost-effective, offering fast response times and being 70 
easily integrated with other devices24. The advantages over conventional analytical 71 
techniques are the possibilities of portability, miniaturisation and ability to measure complex 72 
matrices with minimal sample preparation. Typically, E-DNA biosensors are designed with 73 
the following elements: immobilization of the single-stranded DNA (ssDNA) probe, 74 
hybridisation with complementary target sequence, introduction of an electroactive indicator, 75 
and the electrochemical investigation of the surface25. Differential pulse voltammetry (DPV) 76 
is a convenient electrochemical tool for the detection of DNA, and the signal transducer may 77 
consist of either labelled sequences with an active redox maker, or a double-stranded DNA 78 
(dsDNA) intercalator such as metal ion complexes with iron, cobalt, osmium or ruthenium, 79 
and organic compounds like methylene blue, daunomycin, Hoechst 33258, or anthraquinone 80 
derivates26-28. Amongst these compounds, threading intercalators that carry bulky substituents 81 
on the periphery of the intercalating moiety, are reported to be very efficient and stable to 82 
interact with the DNA duplex28. Naphthalene diimide derivatives (like ferrocenyl derivates) 83 
have been proven to be active candidates as dsDNA intercalators and the constructed 84 
biosensors demonstrate excellent analytical performance for the detection of DNA28, 29.  85 
            Here we present an electrochemical biosensor using a custom synthesized ferrocenyl 86 
(Fc) dsDNA intercalator derived from naphthalene diimide as a redox marker for 87 
amperometric detection. This biosensor is able to detect as low as 10 pM complementary 88 
DNA and is shown to be suitable for single mismatched base pair detection, potentially 89 
enabling the detection of single-nucleotide polymorphism (SNP) cancer markers. Human-90 
specific mtDNA was successfully detected from wastewater using this E-DNA sensor with 91 
and without prior qPCR amplification. To the best of our knowledge, this is the first time a E-92 
DNA biosensor has been reported for the detection of a mtDNA biomarker in wastewater. 93 
We hope this technique may be further improved for the purpose of population DNA 94 
biomarkers study to evaluate public health by means of a WBE approach.  95 
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2. Experimental 96 
2.1 Materials 97 
           Gold disc working electrodes with a radius of 1.0 mm were purchased from IJ 98 
Cambria Scientific Ltd (Cambridge, UK). If not stated otherwise, all chemicals were 99 
purchased from Sigma-Aldrich (UK) and used as received. 100 
            Single stranded DNA, used as reverse and forward primers for PCR amplification, 101 
was synthesized by Eurofins MWG (Ebersberg, Germany). The oligonucleotides used as 102 
DNA probes for the biosensors were modified with a thiol group at the 5’ end to form HS-103 
(CH2)6-ssDNA to assemble on gold electrodes. The thiolated DNA sequences for elaboration 104 
of biosensors were synthesized by Sigma-Aldrich (UK). The sequence 5’-HS-(CH2)6-CCA 105 
CGT CGA GCG ATG-3’ (15 bps) was used as capture probe, and one fully complementary 106 
and three mismatched sequences (5’- CAT CGC TCG ACG TGG-3’, 5’- CAT CGC TCA 107 
ACG TGG-3’, 5’- CAT CGC TAA ACG TGG-3’ and 5’- CAT CGC AAA ACG TGG-3’, 108 
respectively) (Sigma-Aldrich) were employed to hybridize with the DNA probe. The human 109 
specific mtDNA forward and reverse primers20, respectively 5'-CAG CAG CCA TTC AAG 110 
CAA TGC-3 and 5'- GGT GGA GAC CTA ATT GGG CTG ATT AG-3’ were used for PCR 111 
amplification targeting the human mitochondrial gene NADH dehydrogenase subunit 5, and 112 
the modified forms with a HS-(CH2)6 group on the 5’-end of forward and reverse primers 113 
were used for the elaboration of biosensors. Additionally, two thiolated random sequences, 114 
which have the same number of base pairs with either the forward or reverse primer (5'-HS-115 
(CH2)6-AGA AGA AAC GGA GGA AGG GAA-3', 21 bps and 5'- HS-(CH2)6-AAG AAC 116 
TGA AGG GCC AAA TGA GCC GA-3’, 26 bps), were also synthesized for specificity 117 
studies. The HPLC DNA powders were aliquoted in 10 mM Tris-HCl, 1mM 118 
ethylenediaminetetraacetic acid (EDTA) upon receipt and stored in a freezer at -20 oC for 119 
long-term usage. 120 
            The buffer for DNA probe immobilisation (IB) consisted of 0.8 M phosphate buffer 121 
(PB) + 1.0 M NaCl + 5 mM MgCl2 + 1 mM ethylenediamine tetraacetic acid (EDTA) pH 7.0. 122 
The DNA hybridisation and measurement buffer was composed of 50 mM PB and 100 mM 123 
K2SO4 (pH 7.4).   124 
            The influent wastewater was collected from the VEAS wastewater treatment plant 125 
(WWTP; Oslo, Norway), and a sample of pooled urine was collected from portable public 126 
toilets from Oslo during July, 2014. The collected samples were immediately frozen (-20 °C) 127 
and stored frozen until analysis. 128 
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2.2. Synthesis of Fc DNA intercalator 129 
            The synthesis of dsDNA intercalators N,N’-((((((1,3,6,8-tetraoxo-1,3,6,8-130 
tetrahydrobenzo[lmn][3,8]phenanthroline-2,7-diyl)bis(ethane-2,1-diyl))bis(oxy)) bis (ethane-131 
2,1-diyl)) bis(oxy)) bis(ethane-2,1-diyl)) diferrocenamide (1) was generated by N-(2-(2-(2-132 
aminoethoxy)ethoxy)ethyl)-2-ferrocenamide (2) and 1,4,5,8-Naphthalenetetracarboxylic 133 
dianhydride (3). The synthesis procedure is briefly illustrated in Scheme 1, and the detailed 134 
protocol of synthesis and characterization 2 and 1 is described in the supporting information.  135 
 136 
 137 
Scheme 1 138 
 139 
2.3. Elaboration of biosensors 140 
 Gold electrodes were cleaned following a procedure described elsewhere30. In brief, 141 
they were polished with 50 nm aluminium oxide particles (Buehler, USA) on a polishing pad 142 
(Buehler) for 5 min, followed by sonication in ultrapure water, polishing on a blank polishing 143 
pad, and sonication in ultrapure water to remove any particles. Gold electrodes were rinsed 144 
with fresh piranha solution (H2SO4/H2O2, v/v 7/3) followed by rinsing thoroughly with 145 
deionized water, and readily used for electrochemical cleaning. Electrodes were 146 
electrochemically cleaned in a classical three-electrode cell by immersing them into H2SO4 147 
(0.5 M) solution and the potential scanned between the oxidation and reduction potentials of 148 
gold, 0 V and +1.5 V versus an Ag/AgCl reference electrode, with a scanning rate at 0.2 V/s 149 
for 60 cycles until there was no further change in the voltammogram.  150 
 Gold electrodes then were rinsed with deionised water, dried in a stream of nitrogen 151 
and incubated with mixed ssDNA/6-mercapto-1-haxanol (MCH) immobilization solution for 152 
16 h in a humidity chamber at 4 oC. The molar ratio between ssDNA and MCH was 1:3, with 153 
1 µM ssDNA in immobilization buffer. After immobilization, electrodes were rinsed in 50 154 
mM PB + 100 mM K2SO4 + 10 mM EDTA (pH 7.0) to remove any remaining Mg
2+. In order 155 
to ensure complete thiol coverage of the gold surface and make favourable ssDNA 156 
conformation for hybridization, the electrodes were backfilled with MCH (1 mM, H2O) for 1 157 
h, followed by rinsing with ultra-pure water and slightly drying with N2 stream. The 158 
electrodes was electrochemically characterized and then incubated with Fc intercalator at 159 
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desired concentration for 1 h. The electrodes were extensively rinsed with 0.1 % Tween-PB 160 
buffer with vortex for 30 s, followed by rinsing with DI water and drying in N2 stream.            161 
2.4. Isolation and characterization of DNA from wastewater 162 
             The DNA in wastewater from Oslo (sample ‘WW1’) and in the pooled urine (sample 163 
‘WW2’) was isolated with a PowerWater® DNA Isolation Kit (14900-50-NF, (MO BIO 164 
laboratories, Inc), without previous concentration according to manufacturer’s instructions to 165 
obtain 100 µL DNA sample. Sterilized distilled water was included as a negative extraction 166 
control. The concentration of the isolated DNA was determined with a Nanodrop® 167 
spectrophotometer (ND-1000, Nanodrop Technologies, Wilminton, Delaware, USA).  168 
2.5. qPCR analysis of human-specific DNA in wastewater 169 
            Quantitative real-time PCR (qPCR) was performed using a Bio-Rad CFX96 170 
instrument (Bio-Rad Laboratories, Hercules, CA, USA). The human specific mtDNA ND5 171 
primers were used for PCR amplification from wastewater DNA samples20. The final PCR 172 
reaction volume was 15 µL, consisting of 7.5 µL SsoFast mastermix (Bio-Rad) 0.6 µL 173 
reverse and forward primers (0.4 µM final concentration), 2 µL DNA sample and completed 174 
with 4.3 µL  ddH2O. The amplification conditions were modified as following: 2min hot start 175 
step at 98 oC, followed by 35 cycles of 98 oC for 5 s and 60 oC for 5 s. The amplification was 176 
followed by a melt curve analysis with a temperature incrementation of 0.2 oC from 65 oC to 177 
95 oC. A positive control consisting of human blood DNA sample and two negative controls 178 
(one from sterilized water during DNA isolation control and one is non-nucleotide water) 179 
were added in each run of amplification. The amplification was considered to be valid if only 180 
one unique product peak was identified by melting curve analysis.  181 
             Human mitochondrial gene ND5 nucleotide sequences were retrieved from 182 
GeneBank (http://www3.ncbi.nlm.nih.gov), and the PCR amplicon as part of AY972053 was: 183 
5’-CAGCAGCCATTCAAGCAATCCTATACAACCGTATCGGCGATATCGGTTTCATC 184 
CTCGCCTTAGCATGATTTATCCTACACTCCAACTCATGAGACCCACAACAAATAG185 
CCCTTCTAAACGCTAATCCAAGCCTCACCCCACTACTAGGCCTCCTCCTAGCAGC186 
AGCAGGCAAATCAGCCCAATTAGGTCTCCACC (195 bps)-3’. An aliquot (3 µL) of 187 
each amplification reaction was analysed on 1% (w/v) agarose gel in TAE 1x buffer (pH 8). 188 
The image was recorded by Bio-Rad reader (Image Lab 4.1 software). In addition, an 182bp 189 
non-complementary PCR product amplified from the sequence of fibroblast growth factor 190 
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receptor 3 FGFR3 S249C) as described previously31, was randomly used to evaluate the 191 
selectivity of the biosensors. 192 
2.6. Electrochemical characterization of biosensors 193 
 All electrochemical measurements were performed on a three-electrode cell, with an 194 
Ag/AgCl reference electrode (Radiometer Analytical, Lyon, France) against which all 195 
potentials are quoted, and a Pt counter electrode (BASi, USA). Before measurement, 196 
electrodes were placed into measurement buffer for 1 h to stabilize the electrodes. PCR 197 
products were heated at 95 oC for 10 min and then cooled down to room temperature before 198 
the incubation with ssDNA probes.  199 
            Differential pulse voltammetry (DPV) measurements were performed by placing 200 
electrodes in 100 mM PB with Ag/AgCl as reference electrode. DPV scans run between -0.2 201 
V and 0.7 V vs Ag/AgCl (scan rate 0.05 V/s, step potential 0.005 V, modulation amplitude 202 
0.05 V, modulation time 0.05 s, interval time 0.1 s). The schematic illustration of elaboration 203 
of DNA sensors with Fc intercalator as redox marker is presented in Scheme 2.   204 
 205 
Scheme 2 206 
3. Results and discussion 207 
3.1 Development of biosensors based on Fc intercalators 208 
            A crucial control parameter for electrochemical DNA biosensors, is the surface 209 
density of the immobilized ssDNA probe onto the electrode surface in order to effectively 210 
hybridize with complementary DNA. Many studies have shown that a low density of ssDNA 211 
(1-3 x 1012 molecules/cm2) on the surface of the electrodes could achieve high hybridization 212 
efficiency for DNA biosensors30, 32, 33. In our early study30, we optimised the surface density 213 
to maintain high hybridization efficiency by controlling the molar fraction of ssDNA with 214 
MCH on the electrode surface. Here, we used the optimal molar ratio between ssDNA and 215 
MCH (1:3) (ssDNA surface density of 1.6 x 1012 molecules/cm2) in order to allow 216 
complementary DNA to effectively hybridize with the DNA probe. The concentration of Fc 217 
intercalators was optimized to 1 µM for binding with dsDNA. As shown in Figure 1A, the 218 
current peak at around 0.49 V versus Ag/AgCl was associated with the oxidation of ferrocene 219 
on the electrodes. The peak current increases proportionally to complementary DNA 220 
hybridization to the ssDNA probe, enabling target complementary DNA concentration 221 
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measurement. The synthesized dsDNA intercalator can specifically bind with matched bases 222 
in-between the double-helix of DNA; the detailed synthesis and characterization is described 223 
in the supporting information. The number of paired bases on the electrode surface increases 224 
with increasing concentration of complementary DNA, leading to more intercalators to bind 225 
with dsDNA and a current value increase. The signal response to the complementary DNA 226 
hybridization shows a good dynamic range spanning from 10 pM to 100 nM (R2=0.98), and 227 
the limit of detection was determined to be 10 pM (3σ). These results suggest that our custom 228 
synthesized intercalator displays effective and specific binding with the dsDNA.  229 
              Several groups have developed voltammetric biosensors to detect DNA using 230 
different surface modification to improve sensitivity and analytical performances as presented 231 
in Table S1 on the Supplementary Information34-38. As an example, Bo et al35 reported a 232 
voltammetric biosensor based on the chemically modified graphene paste with a limit of 233 
detection of 0.02 nM and a dynamic range of 0.02 - 21.2 nM. Liu et al 36 developed a sensitive 234 
DNA biosensor with a limit of detection at 0.001 nM using a hollow gold nanosphere to 235 
enhance the immobilized DNA probe amount. However, the elaboration of biosensors 236 
required complicated surface coating procedures and allowed non-specific adsorption of the 237 
analyte onto the surface. Compared to those biosensors, the sensor described here could 238 
effectively control the surface density by the molar ratio between the MCH and thiolated 239 
ssDNA. The elaboration procedure was robust, easy-to-operate, time-saving whilst still 240 
sensitive enough for complementary DNA detection at pM range. The stability of the DNA 241 
biosensors was also investigated by storage of the immobilized DNA probes at 4 oC. The 242 
results show that the peak current value from hybridization with the 1 nM complementary 243 
DNA only reduced to 88%, 79.3 % and 68 % following storage for 1, 3 and 7 days, 244 
respectively (See Figure 1). This is due to the robust co-immobilized SAMs layer on the gold 245 
electrodes. 246 
Figure 1 247 
 248 
               In order to further investigate the specific interaction of the Fc intercalator, fully and 249 
partially complementary DNA containing 1, 2 and 3 mismatched base pairs were employed to 250 
hybridize with the ssDNA probe on the electrode. As shown in Figure 1B, the peak current 251 
decreased with the increasing number of mismatched base pairs, suggesting that our Fc 252 
intercalator is able to distinguish a single mismatched base pair, and therefore potentially be 253 
employed for the detection of single-nucleotide polymorphisms (SNPs) disease biomarkers. 254 
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The naphthalene diimide moiety in the Fc intercalator is able to insert or intercalate between 255 
adjacent base pairs of dsDNA. The intercalator carries bulky ferrocene on the periphery of 256 
intercalating moiety, and it becomes placed in the major and minor grooves simultaneously 257 
when intercalated to the DNA duplex39. This kind of intercalator has a strong affinity with 258 
dsDNA because of this peculiar binding mode, and enables to easily discriminate between 259 
double- and single-stranded DNA with a large margin. More importantly, due to its highly 260 
specific affinity to well matched base pairs it can even discriminate a single mismatched base 261 
pair. SNPs are the most common type of genetic variation among people, and each SNP 262 
represents a difference in a single DNA nucleotide. In this study, we investigate feasibility for 263 
SNPs detection in wastewater samples for the purpose of public health epidemiology. Pänke 264 
et al25 electrochemically detected single base-pair mismatch using a competitive binding 265 
assay between un-labelled and labelled DNA with an electroactive redox-marker methylene 266 
blue, and methylene blue was also demonstrated to be useful for the detection of point 267 
mutation in DNA voltammetric biosensor40. In our study, we simply use the affinity between 268 
Fc intercalator and fully/partially matched base pairs to transduce the signal, which is label-269 
free and rapid for single base-pair mismatch detection 41. Besides, this intercalator also shows 270 
an enhancement of impedimetric signal not only for DNA hybridization (see Figure S9) but 271 
also for aptamer sensors for the detection of protein41. Furthermore, to evaluate the feasibility 272 
of E-DNA biosensor for the detection of complex matrix, 1 µM fully complementary DNA 273 
(5’- CAT CGC TCG ACG TGG-3’, 15 bps) was spiked into wastewater and deionized water 274 
for assay, respectively, the peak values from all the blanks are negligible (0.02 µA in buffer, 275 
0.04 µA in wastewater and 0.03 I deionized water), indicating that our sensors are specific for 276 
complex matrices detection. The peak value (3.95 µA) from DNA spiked in wastewater is 277 
only slightly higher than that (3.72 µA) in buffer, and the current value (3.61 µA) from DNA 278 
spiked in deionized water is a bit lower than that in buffer. However, in general the responses 279 
of the spiked DNA samples in three matrixes are not significant.  280 
3.2 qPCR analysis of human-specific mitochondrial DNA from wastewater  281 
             In addition to mtDNA mutations associated to cancer21, 22, mutations in the ND5 282 
subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative 283 
phosphorylation disease42. Therefore, the ND5 sequence could potentially be used as a 284 
population biomarker candidate. DNA was extracted from the Oslo wastewater sample WW1) 285 
and the pooled urine sample WW2; human-specific mtDNA was amplified by qPCR and the 286 
product specificity was checked by melting curves analysis and gel electrophoresis. The 287 
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qPCR protocol20 was modified for the optimal use of the qPCR instrument and the reagents 288 
used in this study. A human DNA sample was included as a positive control (PC), and two 289 
negative controls were amplified (one from sterilized water during DNA isolation control 290 
NC1, another from non-nucleoid water NC2). As shown in Figure 2A, the PC sample yielded 291 
the highest signal, followed by WW2 and then WW1 samples. This correlated well with the 292 
fact that the mtDNA template content in WW1 was less than that in WW2 due to around 1-10 293 
dilution factor for WW1 collected from the wastewater treatment plant. Figure 2B presents 294 
the melting curve of the PCR amplicons. A single well defined melting peak at around 83 oC 295 
was observed for both the samples studied and the human positive control sample confirming 296 
the specificity of the PCR amplification. Furthermore, specificity was also confirmed by gel 297 
electrophoresis showing a product size corresponding to the expected 195 bp (see Fig 2C). 298 
The two negative controls show no or negligible amplification, confirming that the tested 299 
positive samples are true positives. We can therefore conclude that the DNA sample 300 
preparation and qPCR assay produced specific and quantitative results from urine and 301 
wastewater samples.   302 
Figure 2 303 
 304 
3.3. Detection of human specific mtDNA from wastewater with developed biosensors 305 
             The thiolated forward and reverse primers were separately immobilized onto 306 
electrodes for the detection of mtDNA qPCR products from the three tested samples: PC, 307 
WW1 and WW2. The measurements were performed using the same procedure as applied to 308 
the standard samples and the developed biosensor. As shown in Figure 3, three PCR samples 309 
(PC, WW1 and WW2) diluted 1 in 50, were hybridized with two different probes on the 310 
sensor and the current peak at around 0.49 V versus Ag/AgCl, attributed to the oxidation 311 
peak of the Fc intercalator, was obtained from both probes each binding with each of the 312 
three samples. The peak current value, proportional to the concentration of mtDNA PCR 313 
products, is the highest for PC and it shifts to lower values in the urine-pool WW2 and 314 
wastewater WW1 due to the decreased concentration of mtDNA amplicons. The results are in 315 
good agreement with the qPCR results (Figure 2). However, the peak current value (0.17 µA) 316 
from the forward primer probe (21 bp) is lower than that (0.20 µA) from the reverse primer 317 
probe (26 bp) when detecting the same WW2 sample. This is due to the fact that the reverse 318 
primer contains 5 more bases than the forward one, therefore resulting in more Fc 319 
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intercalators interacting with dsDNA on the electrodes. The highest peak current was 320 
achieved using the reverse primer as probe and therefore this probe was selected for further 321 
detection.  322 
Figure 3 323 
 324 
            In order to evaluate the specificity of the binding between the ssDNA probes and the 325 
PCR products, two thiolated ssDNA that contain the same number of bases as either the 326 
forward or the reverse primers and are non-complementary to the mtDNA PCR product 327 
sequence, were immobilized and named probe F(non) and probe R(non). Figure 4A presents 328 
the peak current value obtained from the 4 different probes with WW1 PCR products diluted 329 
1 in 50. The peak currents from non-complementary probes are low compared to those from 330 
complementary ones, indicating that the intercalator could specifically bind with matched 331 
base pairs. The same experiment was performed in the analysis of the WW2 sample, which 332 
shows similar results (Figure 4B). Though there are small peaks from the non-complementary 333 
probes, it is likely that the long-sequence mtDNA may foul the electrode surface introducing 334 
spurious effects. To further determine the non-specific adsorption of probes, a non-335 
complementary PCR product (182 bps) diluted 1 in 50 was introduced to hybridize on a 336 
probe R electrode under the same conditions. As shown in Figure 4C, the current signal from 337 
non-complementary sample gives a negligible signal. These results demonstrate that the 338 
biosensors can specifically detect human mtDNA PCR products extracted from wastewater 339 
using the custom synthesized ferrocenyl intercalator.  340 
 341 
Figure 4  342 
 343 
            The optimized biosensor was used to detect mtDNA of PCR products from WW1 and 344 
WW2 with various dilution factors. As shown in Figure 5, the peak current signal decreased 345 
with the increasing dilution-factor for WW1 and WW2, displaying a good dynamic range 346 
spanning from dilution-fraction 1/5 to 1/100, with a LOD determined to be 7.1 nM from 347 
WW1 and 4.4 nM from WW2 (1/100 and 1/200 dilution respectively; the concentration was 348 
measured with a spectrophotometer). The threshold value was determined from the average 349 
signal of blanks (“PCR non-com”) plus 3 times standard deviation. However, to obtain a 350 
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more reliable threshold value, a cohort of non-complementary PCR products may need to be 351 
evaluated. On the basis of these promising results, we then attempted to directly detect target 352 
DNA from the WW1 (12.2 µg/mL) and WW2 (33.7 µg/mL) samples (extracted from 100 mL 353 
wastewater) without PCR amplification. Although the peak current values obtained were 354 
quite close to that from non-complementary PCR products (Figure 5C), WW2 was above the 355 
threshold while WW1 scored negative. This difference is quite understandable since WW2 is 356 
undiluted urine, while WW1 is approximately 1% urine. Wastewaters are complex matrices 357 
with a high bacterial content along with diverse cell residues from plants and animals aside of 358 
human shed material. Such a dilution of the target human DNA, along with the interference 359 
of non-target DNA is expected to be challenging for direct detection as signal may also be 360 
associated to non-specific adsorption from self-fouling of long DNA sequences. However, 361 
the concentrated DNA extracted from pooled urine (WW2) produced a stronger signal than 362 
that obtained with WW1, as expected as it is likely to contain proportionally more target 363 
human DNA, as already shown by qPCR. To our knowledge this is the first time that an E-364 
DNA biosensor is used for direct detection of target DNA from a wastewater sample. The  365 
 366 
Figure 5  367 
 368 
            Although direct detection and quantification of human mtDNA from extracted 369 
wastewater samples remains challenging, we believe that this proof-of-concept study will 370 
accelerate the development of ultrasensitive biosensing technology for the analysis of 371 
biomarkers in wastewater for epidemiology studies. For example, this system may be further 372 
improved by using nanomaterials for signal enhancement43 for a more sensitive DNA 373 
biomarker analysis in wastewater without PCR amplification.  374 
            In summary, a sensitive E-DNA biosensor using a custom synthesized Fc intercalator 375 
as the electrochemical signal transducer was developed. The optimized biosensor could detect 376 
complementary DNA at concentrations as low as 10 pM with a dynamic range spanning from 377 
10 pM to 100 nM, also enabling the detection of single nucleotide mismatches. To further 378 
evaluate the feasibility of using this technology for analysing human population DNA 379 
biomarkers from wastewaters, primers designed to amplify human-specific mtDNA were 380 
used for qPCR from wastewater and pooled urine samples. Serial dilutions of the human 381 
mtDNA PCR products were specifically detected by the customized biosensors down to a 382 
13 
 
200-fraction dilution (4.4 nM). Furthermore, E-DNA biosensors appear well suited for 383 
implementation in portable PCR microdevices directed at the rapid detection of DNA 384 
biomarkers 44, including wastewater for the purpose of WBE. Finally, our study demonstrates 385 
the feasibility of analysing human specific DNA biomarkers directly in wastewater by using 386 
an E-DNA biosensor. This shows that E-DNA biosensors have a strong development 387 
potential for the monitoring of DNA-disease biomarkers in wastewater, such as SNPs, for the 388 
evaluation of public health by WBE.  389 
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 545 
 546 
 547 
Captions:  548 
Scheme 1 Synthesis of Fc dsDNA intercalator 549 
Scheme 2 Illustration of detection of human mitochondrial DNA from wastewater with 550 
electrochemical biosensor based on Fc intercalator. 551 
 552 
Figure 1 DPV curve of 1 mM ferrocenyl interacalator for the detection of various 553 
concentrations of complementary DNA and the current as the function of the complementary 554 
DNA concentration (insert) (A), and of DPV curve from effects of the number of mismatched 555 
base pairs and the current value as the function of the number of mismatched base pairs 556 
(insert) (B). 557 
Figure 2 Amplified cycles (A) and melting curve (B) of qPCR analysis of mtDNA in 558 
wastewater sample using prime expected products 195 bps, and image (C) of electrophoresis 559 
gel analysis of PCR products with double replicates from each sample. PC: human positive 560 
control, WW1: wastewater treatment plant, WW2: urine pool, NC1: extraction negative 561 
control, NC2: qPCR mastermix negative control.  562 
Figure 3 DPV curve of detection of human sample (PC), WW1 and WW2 samples amplified 563 
with PCR using thiolated forward (A) and reverse (B) primers as probes 564 
Figure 4 Detection of PCR products (1/50 dilutions) of WW1 (A) and WW2 (B) with 565 
different thiolated probes (probe F: thiolated forward primer; probe R: thiolated reverse 566 
primer probe; F/R (non): 21/26 bps non-complementary to the mtDNA PCR product), and (C) 567 
current signal response to the complementary and non-complementary PCR products 568 
hybridisation to probe R. 569 
Figure 5 Detection of WW1 (A) and WW2 (B) PCR product serial dilution, and (C) the 570 
current response from the detection of mtDNA extracted from wastewater with/without PCR 571 
amplification, reference PCR products of WW1 and WW2 were diluted 1 in 50.  572 
 573 
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Schemes and Figures 581 
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Scheme 1 Synthesis of Fc dsDNA intercalator 585 
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Scheme 2 Illustration of detection of human mitochondrial DNA from wastewater with 604 
electrochemical biosensor based on Fc intercalator. 605 
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Figure 1 DPV curve of 1 mM ferrocenyl interacalator for the detection of various concentrations of 619 
complementary DNA and the current as the function of the complementary DNA concentration 620 
(insert) (A), and of DPV curve from effects of the number of mismatched base pairs and the current 621 
value as the function of the number of mismatched base pairs (insert) (B). 622 
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Figure 2. Amplified cycles (A) and melting curve (B) of qPCR analysis of mtDNA in wastewater 641 
sample using prime expected products 195 bps, and image (C) of electrophoresis gel analysis of PCR 642 
products with double replicates from each sample. PC: human positive control, WW1: wastewater 643 
treatment plant, WW2: urine pool, NC1: extraction negative control, NC2: qPCR mastermix negative 644 
control.  645 
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Figure 3 DPV curve of detection of human sample (PC), WW1 and WW2 samples amplified with 662 
PCR using thiolated forward (A) and reverse (B) primers as probes 663 
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Figure 4 Detection of PCR products (1/50 dilutions) of WW1 (A) and WW2 (B) with different 677 
thiolated probes (probe F: thiolated forward primer; probe R: thiolated reverse primer probe; F/R 678 
(non): 21/26 bps non-complementary to the mtDNA PCR product), and (C) current signal response to 679 
the complementary and non-complementary PCR products hybridisation to probe R. 680 
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 689 
Figure 5 Detection of WW1 (A) and WW2 (B) PCR product serial dilution, and (C) the current 690 
response from the detection of mtDNA extracted from wastewater with/without PCR amplification, 691 
reference PCR products of WW1 and WW2 were diluted 1 in 50.  692 
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